Skip to main content

Table 2 Comparison of 18F-FDG PET/CT and 18F-FAPI PET/CT for the intrahepatic lesions of 67 patients

From: Head-to-head comparison of 18F-FAPI and 18F-FDG PET/CT in staging and therapeutic management of hepatocellular carcinoma

Description of lesions

No. of patients  (No. of lesions)

18F-FDG PET/CT

18F-FAPI PET/CT

P value

(FDG vs. FAPI)

Positive detection of lesions(%)

Median SUVmax (range)

Median TBR (range)

Positive detection of lesions(%)

Median SUVmax (range)

Median TBR (range)

SUVmax

TBR

Total

67

35(52.2%)

5.3(2.3–22.5)

2.1(1.0–15.2)

66(98.5%)

9.9(0.4–24.1)

6.0(0.8–30.0)

 < 0.0001

 < 0.0001

 Primary Tumor

59

31(53.4%)

5.6(2.3–22.5)

2.2(1.0–15.2)

58(98.3%)

9.9(0.4–24.1)

6.7(0.8–30.0)

 < 0.0001

 < 0.0001

  T1

16

5(31.3%)

3.75(2.3–11.2)

1.5(1.0–4.3)

15(93.8%)

4.65(0.4–15.2)

3.6(0.8–27.8)

0.1305

 < 0.0001

  T2

13

5(38.5%)

5.3(2.3–22.5)

1.7(1.4–9.8)

13(100%)

9.9(4.6–15.6)

5.0(1.5–15.0)

0.0339

0.0002

  T3

14

5(35.7%)

5.5(3.7–15.5)

2.1(1.3–6.4)

14(100%)

10.9(3.3–24.1)

6.6(2.6–30.0)

0.0085

0.0001

  T4

16

16(100%)

14.5(4.1–18.4)

3.5(1.9–15.2)

16(100%)

12.9(2.2–22.9)

10.2(4.1–22.5)

0.0457

 < 0.0001

 Recurrent Tumor

8

4(50.0%)

3.6(2.4–11.8)

1.4(1.0–5.2)

8(100%)

9.8(2.9–16.8)

5.4(2.6–12.9)

0.0781

0.0078

Tumor Size(cm)

 Total

67(258)

106(41.1%)

4.3(1.3–22.5)

1.7(0.5–15.2)

238(92.2%)

6.7(0.4–24.1)

3.9(0.8–30.0)

 < 0.0001

 < 0.0001

   ≤ 2

NA(110)

28(25.5%)

3.7(1.3–9.8)

1.5(0.5–4.3)

97(88.1%)

5.9(1.2–18.3)

3.1(0.8–22.9)

 < 0.0001

 < 0.0001

   > 2, ≤ 5

NA(89)

34(38.2%)

4.2(2.2–13.8)

1.6(0.8–10.3)

82(92.1%)

6.5(0.4–22.4)

3.8(0.8–30.0)

 < 0.0001

 < 0.0001

   > 5

NA(59)

44(74.6%)

7.1(3.7–22.5)

2.5(1.3–15.2)

59(100%)

11.2(2.2–24.1)

6.6(2.6–26.1)

 < 0.0001

 < 0.0001

No. of lesions

 Solitary

32(32)

12(37.5%)

4.35(2.3–22.5)

1.7(1.0–9.8)

31(96.9%)

6.35(0.4–15.6)

5.15(0.8–27.8)

0.0152

 < 0.0001

 Multifocal

35(226)

94(41.6%)

4.3(1.3–18.4)

1.7(0.5–15.2)

207(91.6%)

6.7(1.2–24.1)

3.8(0.8–30.0)

 < 0.0001

 < 0.0001

Macrovascular invasion

18(18)

18(100%)

5.6(2.7–23.3)

3.5(1.4–12.3)

16(88.9%)

4.65(0.5–8.2)

2.9(1.2–4.6)

0.007

0.043

  1. Bold fonts indicate significant difference between FDG and FAPI (P < 0.05)
  2. 18F Fluorine 18, FDG fluorodeoxyglucose, FAPI fibroblast activation protein inhibitor, PET/CT positron emission tomography/computed tomography, HCC hepatocellular carcinoma, SUVmax maximum standardized uptake value, TBR Tumor-to-background ratio, NA Not applicable